Composition
each tablet contains Chloroquine diphosphate 250 mg.
Indications
- Prophylaxis and treatment of acute attack of malaria.
- Amoebic hepatitis and Giardiasis.
- Lupus erythematosis and rheumatoid arthritis.
Contra-indications
- During pregnancy.
- In psoriasis.
Precautions
- Caution with patients with impaired kidney or liver functions.
- Caution with patients with psoriasis or history of epilepsy.
- If long term therapy periodic ophthalmological examination on the retina is required.
Dosage
Malaria Dosage
Adult dose (for Malaria) – therapeutics
Initially 4 tablets (single dose). Then 2 tablets after 6 hours. Then 2 tablets once in the 2nd and 3rd day.
Adult dose (for Malaria) – Suppressive
1 tablet/week continued for 6 weeks after the last daily in the exposure in an endemic area.
Children dose (for Malaria) – therapeutics
Initial dose 10 mg./kg. of B. wt. followed by 5 mg./kg. of B. wt. after 6 hours. Then 5mg./kg. B .wt. once daily in the 2nd and 3rd day.
Children dose (for Malaria) – Suppressive
5 mg./kg. B. wt weekly for 6 weeks.
Amoebiasis Dosage
Adult dose (for Amoebiasis): 1 tablet 4 times daily for 2 days followed by 1 tablet 2 times daily for 21 days.
Children dose (for Amoebiasis): 6 mg./kg. of B. wt. 2 times daily for 2 days then 6 mg/kg. of B.wt.. once a day for 3 weeks.
Rheumatoid arthritis Dosage
1 Tablet 3 times daily in combination with acetyl salicylic acid or salicylamide.
Lupus Dosage
1 Tablet 2 times daily for 2 weeks.
Package
Pack of 20, 200 and 1000 tablets in 2, 20 and 100 strips, respectively, each of 10 tablets.
Storage
- Store at temperature not exceeding 30°C.
- Keep in dry place, protect from light.
- Keep out of reach of children.
Council of Arab Health Ministers and Union of Arab Pharmacists |
Produced by: El Nasr Pharmaceutical Chemicals Co. “ADWIC” Abu-Zaabal – A.R.E.. ATC Code: P01BA01
Dr. Ahmad Baker, PharmD
Senior Pharmacist & Health Educator
With over 23 years of clinical experience in hospital and community pharmacy across Egypt and Saudi Arabia, Dr. Ahmad specializes in reproductive health and pharmaceutical safety. He is dedicated to providing evidence-based guidance to empower patients in the MENA region.
Medical Disclaimer: This content is for educational purposes and reflects the latest pharmaceutical protocols. It is not a substitute for personal medical advice. Always consult Dr. Ahmad Baker or your healthcare provider before starting any treatment.

